Insulin pump therapy started at the time of diagnosis : <font color="blue">effects_1</font> on <font color="blue">glycemic_2</font> <font color="blue">control_2</font> <font color="blue">and_2</font> <font color="blue">pancreatic_2</font> <font color="blue">β-cell_2</font> <font color="blue">function_2</font> in type 1 diabetes . 
<br>
<br> BACKGROUND In the interest of preserving residual insulin secretory capacity present at the time of diagnosis with type 1 diabetes ( T1D ) , we compared the <font color="blue">efficacy_1</font> of starting insulin pump therapy at diagnosis with standard multiple daily insulin injections ( MDIs ) . 
<br> METHODS We conducted a prospective , randomized , pilot trial <font color="blue">comparing_1</font> <font color="blue">MDI_1</font> <font color="blue">therapy_1</font> with continuous subcutaneous insulin therapy ( pump therapy ) in 24 patients , 8 - 18 years old , with newly diagnosed T1D. Subjects were evaluated at enrollment and 1 , 3 , 6 , 9 , and 12 months after initial diagnosis of T1D. <font color="blue">Preservation_3</font> <font color="blue">of_3</font> <font color="blue">insulin_3</font> <font color="blue">secretion_3</font> <font color="blue">,_3</font> <font color="blue">measured_1</font> <font color="blue">by_1</font> <font color="blue">mixed_1</font> <font color="blue">-_1</font> <font color="blue">meal_1</font> <font color="blue">-_1</font> <font color="blue">stimulated_1</font> <font color="blue">C_1</font> <font color="blue">-_1</font> <font color="blue">peptide_1</font> <font color="blue">secretion_1</font> <font color="blue">,_1</font> was compared after 6 and 12 months of treatment . Between - group differences in <font color="blue">glycosylated_4</font> <font color="blue">hemoglobin_4</font> <font color="blue">(_4</font> <font color="blue">HbA1c_4</font> <font color="blue">)_4</font> <font color="blue">,_4</font> <font color="blue">continuous_4</font> <font color="blue">glucose_4</font> <font color="blue">sensor_4</font> <font color="blue">data_4</font> <font color="blue">,_4</font> <font color="blue">insulin_4</font> <font color="blue">utilization_4</font> <font color="blue">,_4</font> <font color="blue">anthropometric_4</font> <font color="blue">measures_4</font> <font color="blue">,_4</font> <font color="blue">and_4</font> <font color="blue">patient_4</font> <font color="blue">satisfaction_4</font> <font color="blue">with_2</font> <font color="blue">therapy_2</font> were also compared at multiple time points . 
<br> RESULTS Initiation of pump therapy within 1 month of diagnosis resulted in <font color="blue">consistently_1</font> <font color="blue">higher_2</font> <font color="blue">mixed_3</font> <font color="blue">-_3</font> <font color="blue">meal_3</font> <font color="blue">tolerance_3</font> <font color="blue">test_2</font> <font color="blue">-_2</font> <font color="blue">stimulated_2</font> <font color="blue">C_2</font> <font color="blue">-_2</font> <font color="blue">peptide_2</font> <font color="blue">values_2</font> at all time points , although these differences were <font color="blue">not_1</font> <font color="blue">statistically_1</font> <font color="blue">significant_1</font> <font color="blue">._1</font> Nonetheless , <font color="blue">improved_1</font> <font color="blue">glycemic_2</font> <font color="blue">control_2</font> was observed in insulin pump - treated subjects ( more time spent with <font color="blue">normoglycemia_1</font> <font color="blue">,_1</font> <font color="blue">better_1</font> <font color="blue">mean_1</font> <font color="blue">HbA1c_1</font> <font color="blue">)_1</font> , and pump - treated subjects reported <font color="blue">comparatively_1</font> <font color="blue">greater_2</font> <font color="blue">satisfaction_2</font> with route of treatment administration . 
<br> CONCLUSIONS Initiation of insulin pump therapy at diagnosis improved <font color="blue">glycemic_3</font> <font color="blue">control_3</font> <font color="blue">,_3</font> <font color="blue">was_1</font> <font color="blue">well_1</font> <font color="blue">tolerated_1</font> <font color="blue">,_1</font> <font color="blue">and_1</font> <font color="blue">contributed_1</font> <font color="blue">to_1</font> <font color="blue">improved_1</font> <font color="blue">patient_2</font> <font color="blue">satisfaction_2</font> with treatment . This study also suggests that earlier use of pump therapy might help to preserve <font color="blue">residual_2</font> <font color="blue">β-cell_2</font> <font color="blue">function_2</font> <font color="blue">,_2</font> although a larger clinical trial would be required to confirm this .